Phenylpropanolamine toxicosis in dogs: 170 cases (2004-2009)

Journal of the American Veterinary Medical Association

Volumn 239, Issue 11, 2011, Pages 1463-1469

  Peterson, Katherine L ^a,b   Lee, Justine A ^a   Hovda, Lynn R ^a  

^a Division of SafetyCall International   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; PHENYLPROPANOLAMINE;

ANIMAL; CHEMICALLY INDUCED DISORDER; DOG; DOG DISEASE; DOSE RESPONSE; FEMALE; LENGTH OF STAY; MALE; MORTALITY; POISON CENTER; PROGNOSIS; RETROSPECTIVE STUDY; REVIEW; STATISTICS; SURVIVAL;

ANIMALS; DOG DISEASES; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; LENGTH OF STAY; MALE; PHENYLPROPANOLAMINE; POISON CONTROL CENTERS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; SYMPATHOMIMETICS;

ANIMALIA; CANIS FAMILIARIS;

EID: 81355153574     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.239.11.1463     Document Type: Review

References (41)

1. Broadley KJ. The vascular effects of trace amines and amphetamines. Pharmacol Ther 2010;125:363-375.
2. Crandell JM, Ware WA. Cardiac toxicity from phenylpropanolamine overdose in a dog. J Am Anim Hosp Assoc 2005;41:413-420.
3. Plumb DC. Plumb's veterinary drug handbook. 6th ed. Ames, Iowa: Blackwell, 2008.
4. Bacon NJ, Oni O, White RAS. Treatment of urethral sphincter mechanism incompetence in 11 bitches with a sustained-release formulation of phenylpropanolamine hydrochloride. Vet Rec 2002;151: 373-376.
5. Byron JK, March PA, Chew DJ, et al. Effect of phenylpropanolamine and pseudoephedrine on the urethral pressure profile and continence scores of incontinent female dogs. J Vet Intern Med 2007;21:47-53.
6. Richter KP, Ling GV. Clinical response and urethral pressure profile changes after phenylpropanolamine in dogs with primary sphincter incompetence. J Am Vet Med Assoc 1985;187:605-611.
7. Scott LS, Leddy M, Bernay F, et al. Evaluation of phenylpropanolamine in the treatment of urethral sphincter mechanism incompetence in the bitch. J Small Anim Pract 2002;43:493-496.
8. White RAS, Pomeroy CJ. Phenylpropanolamine: an?-adrenergic agent for the management of urinary incontinence in the bitch associated with urethral sphincter mechanism incompetence. Vet Rec 1989;125:478-480.
9. Morgan JP, Funderburk R. Phenylpropanolamine and blood pressure: a review of prospective studies. Am J Clin Nutr 1992;55:206S-210S.
10. Pentel PR, Asinger RW, Benowitz NL. Propranolol antagonism of phenylpropanolamine induced hypertension. Clin Pharmacol Ther 1985;37:488-494.
11. Salerno SM, Jackson JL, Berbano EP. The impact of oral phenylpropanolamine on blood pressure: a meta-analysis and review of the literature. J Hum Hypertens 2005;19:643-652.
12. Blackburn GL, Morgan JP, Lavin, PT, et. al. Determinants of the pressor effect of phenylpropanolamine in healthy subjects. JAMA 1989;261:3267-3272.
13. Lake CR, Zaloga G, Bray J, et al. Transient hypertension after two phenylpropanolamine diet aids and the effects of caffeine: a placebo-controlled follow-up study. Am J Med 1989;86:427-432.
14. Lake CR, Zaloga G, Clymer R, et al. A double dose of phenylpro panolamine causes transient hypertension. Am J Med 1988;85: 339-343.
15. Leo PJ, Hollander JE, Shih RD, et al. Phenylpropanolamine and associated myocardial injury. Ann Emerg Med 1996;28:359-362.
16. Oosterbaan R, Burns MJ. Myocardial infarction associated with phenylpropanolamine. J Emerg Med 2000;18:55-59.
17. Conway EE, Walsh CA, Palomba AL. Supraventricular tachycardia following administration of phenylpropanolamine in an infant. Pediatr Emerg Care 1989;5:173-174.
18. Pentel PR, Mikell FL, Zavoral JH. Myocardial injury after phenylpropanolamine ingestion. Br Heart J 1982;47:51-54.
19. Woo OF, Benowitz NL, Bialy FW, et.al. Atrioventricular conduction block caused by phenylpropanolamine (lett). JAMA 1985;253:2646-2647.
20. Duffy WB, Senekjian HO, Knight TF, et al. Acute renal failure due to phenylpropanolamine. Southern Med J 1981;74:1548-1559.
21. Mueller SM, Muller J, Asdell SM. Cerebral hemorrhage associated with phenylpropanolamine in combination with caffeine. Stroke 1984;15:119-123.
22. Kikta DG, Devereaux MW, Chandar K. Intracranial hemorrhages due to phenylpropanolamine. Stroke 1985;16:510-512.
23. Kernan WN, Viscou CM, Brass LM, et al. Phenylpropanolamine and the risk of hemorrhagic stroke. N Engl J Med 2000;343:1826-1832.
24. Cantu C, Arauz A, Murillo-Bonilla LM, et al. Stroke associated with sympathomimetics contained in over-the-counter cough and cold drugs. Stroke 2003;34:1667-1673.
25. Dietz AJ Jr. Amphetamine-like reactions to phenylpropanolamine. JAMA 1981;245:601-602.
26. Lake CR, Gallant S, Masson E, et al. Adverse drug effects attributed to phenylpropanolamine: a review of 142 case reports. Am J Med 1990;89:195-208.
27. Gunn VL, Taha SH, Liebelt EL, et al. Toxicity of over-the-counter cough and cold medications. Pediatrics 2001;108:1-5.
28. Costanzo LS. Autonomic nervous system. In: Physiology. 2nd ed. Philadelphia: Saunders, 2002;40-56.
29. Long KM, Kirby R. An update on cardiovascular adrenergic receptor physiology and potential pharmacological applications in veterinary critical care. J Vet Emerg Crit Care 2008;18:2-25.
30. Hussain MA, Aungst BJ, Lam G, et al. Phenylpropanolamine pharmacokinetics in dogs after intravenous, oral, and oral controlled- release doses. Biopharm Drug Dispos 1987;5:497-505.
31. Noel S, Cambier C, Baert K, et al. Combined pharmacokinetics and urodynamic study of the effects of oral administration of phenylpropanolamine in female Beagle dogs. Vet J 2010;184:201-207.
32. Root Kustritz MV, Olson PN. Early spay and neuter. In: Ettinger SJ, Feldman EC, eds. Textbook of veterinary internal medicine. 5th ed. Philadelphia: Saunders, 2000;1539-1541.
33. Arnold S, Weber U. Urethral sphincter mechanism incompetence in male dogs. In: Bonagura JD, ed. Kirk's current veterinary therapy XIII small animal practice. Philadelphia: Saunders, 2000;896-899.
34. Arnold S. Relationship of urinary incontinence to neutering. In: Kirk, RW, Bonagura, JD, eds. Kirk's current veterinary therapy XI small animal practice. Philadelphia: Saunders, 1992;875-877.
35. Hovda LR. Toxic exposure in small animals. In: Bonagura JD, ed. Kirk's current veterinary therapy XIV small animal practice. Philadelphia: Saunders, 2009;92-94.
36. Gregory SP. Developments in the understanding of the pathophysiology of urethral sphincter mechanism incompetence in the bitch. Br Vet J 1994;150:135-150.
37. Vick J, Weiss L, Ellis S. Cardiovascular studies of phenylpropanolamine. Arch Int Pharmacodyn Ther 1994;327:13-24.
38. Pentel PR, Jentzen J, Siever J. Myocardial necrosis due to intraperitoneal administration of phenylpropanolamine in rats. Fundam Appl Toxicol 1987;9:167-172.
39. Brown S. Hypertensive crisis. In: Silverstein DC, Hopper K, eds. Small animal critical care medicine. St Louis: Saunders, 2009;176-179.
40. Peterson ME. Toxological decontamination. In: Peterson, ME, Talcott PA, eds. Small animal toxicology. Philadelphia: Elsevier, 2006;127-141.
41. Volmer PA. "Recreational" drugs. In: Peterson, ME, Talcott PA, eds. Small animal toxicology. Philadelphia: Elsevier, 2006;273-311.